Metraipolis › archive › dc_32f45942ff74
A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer — Europe PMC PMID:29374414
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/29374414
- DOI
- 10.22034/apjcp.2018.19.1.283
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T09:18:17.377Z
- SHA-256 of the archived text
778a0bbff582cd92cafe9fcbd7c20a3e4fa54bfd211298fae41012ba9888f5f5- Stable URL of this page
https://metraipolis.com/documento/dc_32f45942ff74
How to cite
A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer — Europe PMC PMID:29374414 — Europe PMC (en), https://europepmc.org/article/MED/29374414 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_32f45942ff74 (Metraipolis archive dc_32f45942ff74, sha256 778a0bbff582cd92cafe9fcbd7c20a3e4fa54bfd211298fae41012ba9888f5f5)
BibTeX
@misc{dc32f45942ff74,
title = {A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer — Europe PMC PMID:29374414},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/29374414},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_32f45942ff74; sha256 778a0bbff582cd92cafe9fcbd7c20a3e4fa54bfd211298fae41012ba9888f5f5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/29374414. Agents can read the archived copy with the MCP tool read_document.